Ignite Creation Date:
2025-12-24 @ 6:44 PM
Ignite Modification Date:
2026-01-04 @ 9:24 AM
Study NCT ID:
NCT06174857
Status:
RECRUITING
Last Update Posted:
2023-12-18
First Post:
2023-12-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of Osimertinib in Patients With Lung Cancer
Sponsor:
Hunan Province Tumor Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
EGFR 19 delins
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None